Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,742 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06821295RecruitingPhase 2/Phase 3
Smartphone app to help reduce drinking at shelters
This trial tests a smartphone app that gives you personal tips to help you drink less alcohol, especially if you are staying at or getting services from a shelter. The app sends you messages at the right times to help you cut back on drinking.
Oklahoma City, OklahomaAges 18 years+ - NCT06821100RecruitingPhase 1
Thymalfasin to Boost COVID-19 Vaccine Response in Older Adults
This trial tests whether a drug called thymalfasin (thymosin alpha 1) can help older adults (65+) get a stronger immune response from their COVID-19 booster shot. It may be especially helpful for those whose immune systems have weakened with age.
Houston, TexasAges 65–100 - NCT06817252Recruiting
Mediterranean diet with potatoes for pre-diabetes
This study tests whether adding potatoes to a Mediterranean diet can improve heart health and blood sugar control in adults with pre-diabetes. You'll follow a specific meal plan and be monitored over time.
Las Vegas, NevadaAges 45–80 - NCT06820658Recruiting
Comparing muscle response in active and inactive older adults
This study looks at how muscles respond to exercise in people aged 60 to 85. You will be asked to do some exercises so researchers can measure how your nerves and muscles work together.
Rochester, MinnesotaAges 60–85 - NCT06822231Recruiting
High-tech rehab for acute neuromuscular diseases
This study tests a high-tech rehab program using robots and advanced tools to help people recover from acute neuromuscular diseases. It aims to see if this approach improves leg strength and mobility better than standard care.
BariAges 18–80 - NCT01055093Recruiting
Study of diabetes complications in adults soon after diagnosis
This study follows adults who have been diagnosed with diabetes recently to better understand diabetes and its complications over time. It also includes a comparison group of people who do not have diabetes to help researchers see what changes are linked to diabetes.
Düsseldorf, North Rhine-WestphaliaAges 18–69 - NCT06812078RecruitingPhase 2
TAK-360 for idiopathic hypersomnia
This study tests an investigational medication called TAK-360 for people with idiopathic hypersomnia (IH), a sleep disorder that causes excessive daytime sleepiness. The goal is to see if the drug can help reduce sleepiness and improve daily function.
Redwood City, CaliforniaAges 18–70 - NCT06808477RecruitingPhase 1
BBT001 for moderate to severe eczema
This trial tests an experimental drug called BBT001 for people with moderate to severe eczema (atopic dermatitis) that hasn't been helped enough by creams. The study is in early phases, so it will check how safe the drug is and how well it might work.
Irvine, CaliforniaAges 18–72 - NCT06803680RecruitingPhase 1
Study of BGB-B455 for advanced solid tumors
This trial tests a new drug, BGB-B455, for people with advanced solid tumors that have not responded to other treatments. It focuses on tumors that have a specific marker called CLDN6, especially in ovarian cancer.
Celebration, FloridaAges 18 years+ - NCT06805305RecruitingPhase 2
Immunotherapy for newly diagnosed glioblastoma
This trial tests a new personalized immunotherapy (DOC1021) for people with newly diagnosed glioblastoma. The treatment uses your own immune cells to attack the tumor and is given after surgery and with standard chemotherapy and radiation.
Gilbert, ArizonaAges 18 years+ - NCT06809179RecruitingPhase 2
Nasal spray for social anxiety
This study tests if a new nasal spray called fasedienol helps quickly reduce anxiety in adults with social anxiety disorder. The spray is used as needed in a repeat-dose design, meaning you might use it more than once.
Sherman Oaks, CaliforniaAges 18–65 - NCT06805175Recruiting
Balance implant study for adults with dizziness
This study tests a new device that may help restore balance for people with long-term dizziness from inner ear problems. The implant is placed surgically to stimulate the balance nerve.
Antwerp, WilrijkAges 18 years+ - NCT06811324RecruitingPhase 2
Tirzepatide for muscle and vessel health in older adults
This study tests if the drug tirzepatide can improve muscle and blood vessel health in older adults with obesity. You may be eligible if you are 50 or older, have a BMI between 30 and 40, and do not have diabetes.
San Antonio, TexasAges 50 years+ - NCT06812598Recruiting
Extended letermovir to prevent CMV after stem cell transplant
This trial tests whether taking letermovir for a longer time can prevent CMV (a common virus) from reactivating in adults with certain risk factors after a donor stem cell transplant. If you're preparing for your first transplant and have a high-risk donor or conditioning, this study may be an option.
Suzhou, JiangsuAges 18 years+ - NCT06812143Recruiting
Strength Training Study for Adults 65 and Older
This study tests a strength training program designed for older adults who are not currently active. The goal is to find the best way to improve strength and overall health in people over 65.
Flushing, New YorkAges 65 years+ - NCT06803771Recruiting
Checking pancreas health after a new diabetes diagnosis
This study looks at people recently diagnosed with type 2 diabetes to check their pancreas health using blood tests and scans. The goal is to find early signs of pancreatic issues, which might help catch problems sooner.
Sandbach, CheshireAges 50–84 - NCT06814717RecruitingPhase 2
Study of cP12 for adults with small burns
This trial tests a new drug called cP12 given through a vein to see if it is safe and how the body handles it. It is for adults who have a thermal burn covering 10% or less of their body within the first 2 to 24 hours after the burn happened.
Washington D.C., District of ColumbiaAges 18–65 - NCT06809387Enrolling by invitation
Magnetic brain stimulation for stuttering and reading in adults
This study tests whether a gentle magnetic stimulation technique called rTMS can help improve speech and reading fluency in adults who have stuttered since childhood. It aims to understand how a brain area involved in movement planning might play a role in stuttering.
IstanbulAges 18 years+ - NCT06814184Recruiting
Virtual diabetes care for adults with type 2 diabetes on Medicaid and insulin
This study tests a virtual (remote) diabetes care program for adults with type 2 diabetes who are on insulin and have Medicaid insurance. It aims to help improve blood sugar control using a smartphone app or text messages.
New Brunswick, New JerseyAges 18–90 - NCT06808828Recruiting
Occupational therapy for survivors of partner violence
This trial tests if occupational therapy can help adults who have experienced intimate partner violence improve daily living skills and well-being. It is open to anyone 18 or older already getting help from a domestic violence organization.
Loma Linda, CaliforniaAges 18–70 - NCT06809166RecruitingPhase 4
Contrave for weight loss in adults with obesity
This study tests whether a weight loss medication called Contrave can help adults with obesity lose weight by changing how their body uses energy and handles food. If you qualify, you will take Contrave and be monitored for several months.
Ottawa, OntarioAges 18–64 - NCT06804109Recruiting
Nerve stimulation and cognition in young adults who vape
This study tests whether a gentle, non-invasive nerve stimulation device (placed on the neck) can affect thinking and attention in young adults who vape. You'd attend a single session where you receive the stimulation or a placebo while doing simple computer tasks.
Philadelphia, PennsylvaniaAges 18–25 - NCT06796686RecruitingPhase 1
HIV vaccine safety and immune response study for healthy adults
This trial tests a new two-part HIV vaccine regimen in healthy adults without HIV. The goal is to see if it is safe and produces an immune response that could help prevent HIV.
San Francisco, CaliforniaAges 18–55 - NCT06797518RecruitingPhase 2
Testing iptacopan for IgA nephropathy kidney changes
This study tests if adding iptacopan to standard care can improve kidney health in adults with IgA nephropathy. You may qualify if you have a kidney biopsy confirming IgA nephropathy and your kidney function is stable enough.
Birmingham, AlabamaAges 18–99
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,742 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.